Keylight vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 39)

Keylight

EmergingSubscription Services

General

Berlin bootstrapped subscription management and billing platform at $2.9M revenue 2024 with 30 employees; Gartner Magic Quadrant Visionary 2024 for Recurring Billing competing with Zuora for user-centric B2B/B2C subscription commerce.

AI VisibilityBeta
Overall Score
D39
Category Rank
#234 of 1167
AI Consensus
59%
Trend
stable
Per Platform
ChatGPT
35
Perplexity
35
Gemini
35

About

Keylight is a Berlin, Germany-based subscription management and recurring billing software platform — bootstrapped with $2.9 million in 2024 revenue (up from $2.1 million in 2023) and 30 employees — providing B2B and B2C subscription businesses in SaaS, e-commerce, financial services, energy and utilities, and manufacturing/IoT sectors with a unified platform for omnichannel commerce, subscription lifecycle management, CPQ (Configure, Price, Quote), billing automation, and revenue accounting. Named a Visionary in the 2024 Gartner Magic Quadrant for Recurring Billing Applications, Keylight differentiates from traditional finance-centric billing platforms through a user-centric architecture that prioritizes customer journey configurability and partner portal self-service alongside backend billing automation. Founded in 2015 by Daniel Werner (CEO) and Marco Sarich (Managing Director), operating across EMEA, North America, and APAC.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

39
Overall Score
90
#234
Category Rank
#9
59
AI Consensus
60
stable
Trend
stable
35
ChatGPT
99
35
Perplexity
99
35
Gemini
83
32
Claude
96
49
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.